Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
140 hedge funds and large institutions have $521M invested in Surmodics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 50 reducing their positions, and 25 closing their positions.
1,381% more call options, than puts
Call options by funds: $24.4M | Put options by funds: $1.65M
3.32% more ownership
Funds ownership: 86.87% → 90.19% (+3.3%)
8% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 50
2% more capital invested
Capital invested by funds: $509M → $521M (+$12.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 151 → 140 (-11)
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$6.83M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$5.15M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.82M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.68M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.08M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.83M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.71M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.49M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.17M |
SRDX Hedge Fund Activity: Q2 2019 in Review
140 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2019, worth a combined $521M — up 2.4% from $509M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SRDX and 17 opened new positions — a net loss of 8 holders — while 50 trimmed existing stakes and 54 added.
The largest buyer was Nuveen, opening a new position worth an estimated $6.83M. The largest seller was Deutsche Bank, cutting an estimated $4.08M.
- 140 institutional investors held Surmodics (SRDX) as of Q2 2019, down from 151 in Q1 2019.
- Funds reported $521M of Surmodics stock for Q2 2019, up 2.4% quarter-over-quarter.
- 17 funds opened new Surmodics positions in Q2 2019 and 25 closed out, a net change of -8 holders.
- The largest Surmodics buyer in Q2 2019 was Nuveen, an estimated $6.83M added.
- The largest Surmodics seller in Q2 2019 was Deutsche Bank, an estimated $4.08M sold.
Based on aggregated 13F filings for Q2 2019.